Related Experiment Videos
NK binding capacity and lytic activity depend on the expression of ICAM-1 on target bone tumours
A Meneghetti1, E Mariani, S Santi
1Laboratorio di Immunologia e Genetica, Istituto di Ricerca Codivilla Putti-IOR, 40136 Bologna, Italy.
Abstract:
Osteosarcoma cell lines are differently lysed by natural killer (NK) lymphocytes. A critical step in the lytic process is the recognition and attachment of effector to target cells. To determine binding capacity and lytic activity of NK cells, we investigated the distribution and role of ICAM-1, 2 and 3 on two osteosarcoma cell lines (HOS and Saos-2) in basal conditions and after TNFalpha treatment. Modulation of ICAM-1 after TNFalpha treatment modified the binding capacity of NK cells to osteosarcoma target cells. This modulation process appears to play a critical role in determining the susceptibility of these cells to NK-mediated lysis.
Insights
Natural killer (NK) cells lyse osteosarcoma differently. Intercellular Adhesion Molecule-1 (ICAM-1) modulation on osteosarcoma cells impacts NK cell binding and lysis susceptibility, crucial for NK-mediated tumor cell killing.
Area of Science:
- Immunology
- Oncology
- Cell Biology
Background:
- Natural killer (NK) lymphocytes play a role in tumor surveillance.
- Osteosarcoma cell lines exhibit varying susceptibility to NK cell-mediated lysis.
- Intercellular Adhesion Molecule (ICAM) expression is critical for immune cell interactions.
Purpose of the Study:
- To investigate the distribution and function of ICAM-1, ICAM-2, and ICAM-3 on osteosarcoma cell lines.
- To determine the effect of TNF-alpha on ICAM expression and NK cell binding.
- To elucidate the role of ICAMs in NK cell-mediated lysis of osteosarcoma.
Main Methods:
- Analysis of ICAM-1, -2, and -3 expression on HOS and Saos-2 osteosarcoma cell lines.
- Treatment of cell lines with TNF-alpha to modulate ICAM expression.
- Assessment of NK cell binding capacity to osteosarcoma cells.
- Evaluation of NK cell-mediated lysis of osteosarcoma cells.
Main Results:
- Osteosarcoma cell lines displayed differential lysis by NK cells.
- TNF-alpha treatment modulated ICAM-1 expression on osteosarcoma cells.
- Modulation of ICAM-1 affected NK cell binding capacity to target cells.
- ICAM-1 expression changes correlated with NK cell-mediated lysis susceptibility.
Conclusions:
- ICAM-1 plays a significant role in the interaction between NK cells and osteosarcoma cells.
- Modulation of ICAM-1 influences the susceptibility of osteosarcoma to NK cell lysis.
- Targeting ICAM-1 could be a strategy to enhance NK cell-based immunotherapy for osteosarcoma.